Navigation Links
Wayne State researchers seek calcium channels to target cancer tumors
Date:4/22/2013

DETROIT Two Wayne State University researchers are working on a technique that could lead to easier, faster identification of cancer tumors that can be effectively treated by calcium channel-based therapies.

Rod Braun, Ph.D., associate professor of anatomy and cell biology in the School of Medicine, recently received a two-year, $322,000 grant from the National Cancer Institute of the National Institutes of Health to use manganese-enhanced magnetic resonance imaging (MEMRI) to noninvasively determine the activity of different calcium channels in tumors. He and co-principal investigator Bruce Berkowitz, Ph.D., professor of anatomy and cell biology and ophthalmology, and director of the School of Medicine's Small Animal MRI Facility, are hoping the technique can be used to guide and individualize calcium channel-based treatment of cancer.

Previous research has shown that different types of cancer cells highly express a number of plasma membrane calcium channels, making them important potential therapeutic targets in tumors. Drugs that target specific calcium channels already exist, and several are currently in Phase I clinical trials as anti-cancer agents.

"Unfortunately, it is difficult to determine whether a specifically targeted calcium channel is present in an individual patient's tumor," Braun said.

In their project, "Guiding Ca2+ Channel-Based Cancer Treatment Using Mn2+-Enhanced MRI," he and Berkowitz will use MEMRI to measure tumors' uptake of manganese ion, an MRI contrast agent that largely enters cells via calcium channels. They believe tumor uptake of manganese in the presence of antagonist compounds, which block calcium channels, and agonist compounds, which stimulate them, can be measured using MEMRI, thereby proving useful in predicting potential tumor response to calcium-channel based therapies.

The project has two components. The first will test manganese uptake of prostate, breast and colorectal cancer tumor cells in tissue culture; the second will test it in solid human tumors growing in mice.

"We have an innovative technique that offers promise for identifying which tumors can be effectively treated with drugs that currently are in clinical trials," Braun said. "If it turns out we can use MEMRI in this way, we could see if a patient's tumor expresses specific calcium channels and then select the best treatment for targeting these particular channels. That would allow us to determine which patients would benefit from these drugs and which drugs will be most therapeutic.

"Not every therapy works against every tumor, and MEMRI may allow us to select the best treatment for a given patient. This technique's major benefits are that it is noninvasive and can quickly lead to individualized therapy."


'/>"/>

Contact: Julie O'Connor
julie.oconnor@wayne.edu
313-577-8845
Wayne State University - Office of the Vice President for Research
Source:Eurekalert

Related medicine news :

1. Wayne State University researcher examines proteins role in diabetic retinopathy
2. Wayne State University researcher seeks to understand link between obesity, flu severity
3. Algae extract increases good cholesterol levels, Wayne State research finds
4. Wayne State develops better understanding of memory retrieval between children and adults
5. Wayne State research team finds possible clue to progression of MS
6. Wayne State researchers say adolescent smoking prevention programs still critical
7. Wayne State University researcher recognized by American Psychological Association
8. CDC funds Wayne State University research to understand, prevent teen dating violence
9. Wayne State researcher finds possible clue to childrens early antisocial behavior
10. Wayne State University researcher to evaluate success of text message diabetes intervention
11. Wayne State embarks on study to improve identification of women at high risk of stroke
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... BROOK, Ill. (PRWEB) , ... February 20, 2017 ... ... potential to reduce the rate at which women are called back for additional ... the journal Radiology . , In 2011, the U.S. Food and Drug ...
(Date:2/20/2017)... ... 20, 2017 , ... Daily Body Restore, "DBR" a company ... “good” bacteria in the body, announced its Daily Body Restore® supplement is now ... Body Restore® is made with a unique combination of digestive enzymes and probiotics ...
(Date:2/20/2017)... ... February 20, 2017 , ... For Immediate Release, ... a leading provider of innovative software for connected home healthcare, today announced ... care journey management for home healthcare. , Built on Orbita Health ...
(Date:2/20/2017)... Yardley, PA (PRWEB) , ... February 20, 2017 , ... ... are collaborating to help health care providers better manage patient health risks, foster behavior ... largest medication video library in the world, will present a demonstration of its video ...
(Date:2/20/2017)... ... February 20, 2017 , ... Best Doctors® and IBM ... benefit for companies that want to help members of their workforce battling cancer. ... access to Watson’s suite of oncology offerings for insights on cancer treatment options, ...
Breaking Medicine News(10 mins):
(Date:2/20/2017)... Provides understanding and access to the ... the worlds leading healthcare companies. Download the ... Global Anemia Partnering Terms and Agreements since 2010 ... and agreements entered into by the world,s leading ... deals - Top deals by value ...
(Date:2/20/2017)... -- This Report analyzes the worldwide markets for Pharmaceutical Contract Manufacturing in ... and Liquid & Semi-solid Dosage Forms. The report provides separate comprehensive ... Japan , Europe , Asia-Pacific ... full report: http://www.reportlinker.com/p04707109-summary/view-report.html ... Annual estimates and forecasts are provided for the ...
(Date:2/20/2017)... Feb. 20, 2017 This report analyzes the worldwide ... market is analyzed by the following Segments: Biologic Meshes, and ... US, Canada , Japan ... , and Rest of World. Read the ... forecasts are provided for the period 2015 through 2022. Also, ...
Breaking Medicine Technology: